mHealth Market

mHealth Market (Product: Connected Medical Devices, mHealth Applications, and mHealth Services; and End-user: B2B and B2C) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

mHealth Market Outlook 2031

  • The global industry was valued at US$ 97.0 Bn in 2022
  • It is estimated to advance at a CAGR of 15.3% from 2023 to 2031 and reach US$ 353.4 Bn by the end of 2031

Analyst Viewpoint

Increase in popularity of remote patient monitoring devices and technological advancements in the healthcare sector are fueling the mHealth market size. mHealth enables monitoring real-time patient information to track their heart rate, sugar levels, blood pressure, and other parameters. Rise in demand for remote patient monitoring devices for chronic diseases is driving the demand for mobile healthcare services.

Surge in adoption of digital health and easy availability of wearable fitness trackers is boosting market expansion. Increase in government initiatives to promote fitness awareness is likely to offer lucrative mHealth market opportunities. Leading companies in the sector are launching new applications with advanced technologies to meet patient demands. Moreover, manufacturers are investing in research and development activities to analyze the requirements of physicians and develop relevant services accordingly.

Mhealth Market

Market Introduction

mHealth or mobile health is a general term for the use of mobile phones and other wireless technology in medical care. mHealth is used to improve health outcomes, research, and healthcare services to enhance patient care. These are available in devices, connections, applications, and service forms. mHealth plays a crucial part in telemedicine by increasing patient interaction and enabling remote data access to healthcare providers.

Digital health is on the rise across the globe due to the availability of advanced technologies and accessibility to modern healthcare services. mHealth enables mobile self-care services for patients suffering from diabetes, chronic diseases, and other health issues. The technology simplifies interaction among patients and allows physicians to access real-time patient data, such as sugar level, blood pressure, and heart rate.

Increase in Popularity of Remote Patient Monitoring Devices Fostering mHealth Market Growth

Remote patient monitoring devices are extensively utilized by healthcare professionals to track patient information and change the treatment mode as per the requirements. Mobile healthcare devices are employed to monitor patient data where patients can update their details at their end. These devices help provide better treatment, increase patient engagement, reduce patient visits to the hospitals, decrease healthcare costs, and keep patient data updated. Thus, increase in popularity of advanced remote patient monitoring devices is fueling mHealth market value.

Rise in demand for remote patient monitoring solutions for chronic conditions is bolstering the market statistics. Chronic conditions, such as diabetes, cancer, and heart disease require regular patient data monitoring to avoid severe issues and disabilities. mHealth allows patients to register their blood sugar levels, heart rate, and other symptoms through remote devices. Hence, increase in prevalence of chronic conditions is driving market revenue.

According to the American Hospital Association, around 133 million Americans, nearly half the population, suffer from at least one chronic condition, such as arthritis, hypertension, or heart disease. The number is estimated to reach approximately 170 million by 2030.

Technological Advancements in Healthcare Sector Augmenting Market Development

Increase in penetration of 5G connectivity, artificial intelligence, machine learning, and augmented reality are some of the trending technologies adopted by the healthcare sector. Incorporation of Internet of Things (IoT) in mHealth enhances connectivity and accessibility through remote networks. Leading companies in the market are investing heavily to develop advanced mobile health apps for diabetes management, which in turn is fueling market progress. For instance, AT&T collaborated with Smart Meter to develop advanced digital health solutions for monitoring and tracking chronic ailments, such as diabetes, using Smart Meter’s IoT devices and AT&T’s well-established IoT network.

Rise in demand for wearable fitness trackers for heart rate monitoring is boosting market dynamics. Manufacturers are employing motion detectors, temperature monitors, and sensors to precisely record patient data. People are keen on using wearable fitness trackers due to its high efficiency, accuracy, easy availability, and feasibility.

Regional Outlook

According to the regional mHealth market analysis, North America dominated the global landscape in 2022. Implementation of government initiatives to promote mHealth is likely to propel the mHealth industry share during the forecast period. For instance, the U.S. Department of Health and Human Services, the National Institutes of Health, and the National Cancer Institute initiated Smokefree.gov and BeTobaccoFree.gov, to spread awareness among the population. Leading companies in the region are adopting the latest technologies to introduce new applications and services for patients.

Increase in use of connected devices and mHealth applications to manage chronic conditions is fueling market growth. Availability of strong network connectivity and developed healthcare infrastructure is favoring market conditions in the region. Moreover, easy accessibility to advanced technologies allows companies to develop services according to patient requirements.

Analysis of Key Players in mHealth Industry

Leading companies in the market are focusing on adopting the latest technologies to meet recent mHealth market trends. They are incorporating IoT, artificial intelligence, motion sensors, and temperature trackers into wearable fitness trackers to monitor real-time patient data. Manufacturers are introducing new applications and services to increase patient engagement and enhance their fitness awareness.

Some of the key players in the industry are Dexcom, Inc., Apple, Inc., FitBit, Inc., Withings, Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Teladoc Health, Inc., Noom, Inc., Propeller Health, Canary Health, BiogeniQ Inc., Glooko, Inc., Firstbeat Technologies, and BioTelemetry, Inc.

These companies have been profiled in the mHealth market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In October 2023, Cedars-Sinai, a leading company providing specialty care from expert physicians, introduced a new artificial intelligence-powered mobile health application, the Cedars-Sinai Connect. This application offers virtual care alternatives for various clinical issues with same-day primary care visits and round-the-clock virtual access to medical specialists for urgent treatment.
  • In March 2023, Apple Inc., a multinational technology company, announced plans to upgrade AirPods with health tracking features, including temperature monitors, motion detectors, and biometric sensors to detect perspiration and heart rate, by 2025.

mHealth Market Snapshot

Attribute Detail
Market Size in 2022 US$ 97.0 Bn
Market Forecast (Value) in 2031 US$ 353.4 Bn
Growth Rate (CAGR) 15.3%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Connected Medical Devices
      • Heart Rate Monitors
      • Activity Monitors
      • Electrocardiograph
      • Fetal Monitoring
      • Neuromonitoring
      • Others
    • mHealth Applications
      • Fitness & Wellness
      • Diabetes
      • Cardiovascular Diseases
      • Central Nervous System Diseases
      • Respiratory Diseases
      • Musculoskeletal Diseases
      • Smoking Cessation
      • Medication Adherence
      • Others
    • mHealth Services
  • End-user
    • B2B
      • Patients
      • Caregivers
    • B2C
      • Providers
      • Payers
      • Employers
      • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • Dexcom, Inc.
  • Apple, Inc.
  • FitBit, Inc.
  • Withings
  • Proteus Digital Health, Inc.
  • Omada Health, Inc.
  • Welldoc, Inc.
  • Teladoc Health, Inc.
  • Noom, Inc.
  • Propeller Health
  • Canary Health
  • BiogeniQ Inc.
  • Glooko, Inc.
  • Firstbeat Technologies
  • BioTelemetry, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global mHealth market in 2022?

It was valued at US$ 97.0 Bn in 2022

How is the mHealth sector expected to grow by 2031?

It is projected to register a CAGR of 15.3% from 2023 to 2031

What are the key factors driving the demand for mHealth?

Increase in popularity of remote patient monitoring devices, and growth in technological advancements in the healthcare sector

Which was the most lucrative region in the mHealth industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent mHealth manufacturers?

Dexcom, Inc., Apple, Inc., FitBit, Inc., Withings, Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Teladoc Health, Inc., Noom, Inc., Propeller Health, Canary Health, BiogeniQ Inc., Glooko, Inc., Firstbeat Technologies, and BioTelemetry, Inc.

1. Executive Summary

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global mHealth Market

4. Market Overview

    4.1. Market Segmentation

        4.1.1. Segment Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global mHealth Market Analysis and Forecasts, 2017-2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. COVID-19 Pandemic Impact on Industry

6. mHealth Market Analysis and Forecast, by Product

    6.1. Introduction and Definitions

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Connected Medical Devices

            6.3.1.1. Heart Rate Monitors

            6.3.1.2. Activity Monitors

            6.3.1.3. Electrocardiograph

            6.3.1.4. Fetal Monitoring

            6.3.1.5. Neuromonitoring

            6.3.1.6. Others

        6.3.2. mHealth Applications

            6.3.2.1. Fitness & Wellness

            6.3.2.2. Diabetes

            6.3.2.3. Cardiovascular Diseases

            6.3.2.4. Central Nervous System Diseases

            6.3.2.5. Respiratory Diseases

            6.3.2.6. Musculoskeletal Diseases

            6.3.2.7. Smoking Cessation

            6.3.2.8. Medication Adherence

            6.3.2.9. Others

        6.3.3. mHealth Services

    6.4. Market Attractiveness, by Product

7. Global mHealth Market Analysis and Forecast, by End-user

    7.1. Introduction and Definitions

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. B2B

            7.3.1.1. Patients

            7.3.1.2. Caregivers

        7.3.2. B2C

            7.3.2.1. Providers

            7.3.2.2. Payers

            7.3.2.3. Employers

            7.3.2.4. Others

    7.4. Market Attractiveness, by End-user

8. Global mHealth Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region, 2017–2031

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness, by Region

9. North America mHealth Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2031

        9.2.1. Connected Medical Devices

            9.2.1.1. Heart Rate Monitors

            9.2.1.2. Activity Monitors

            9.2.1.3. Electrocardiograph

            9.2.1.4. Fetal Monitoring

            9.2.1.5. Neuromonitoring

            9.2.1.6. Others

        9.2.2. mHealth Applications

            9.2.2.1. Fitness & Wellness

            9.2.2.2. Diabetes

            9.2.2.3. Cardiovascular Diseases

            9.2.2.4. Central Nervous System Diseases

            9.2.2.5. Respiratory Diseases

            9.2.2.6. Musculoskeletal Diseases

            9.2.2.7. Smoking Cessation

            9.2.2.8. Medication Adherence

            9.2.2.9. Others

        9.2.3. mHealth Services

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. B2B

            9.3.1.1. Patients

            9.3.1.2. Caregivers

        9.3.2. B2C

            9.3.2.1. Providers

            9.3.2.2. Payers

            9.3.2.3. Employers

            9.3.2.4. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product

        9.5.2. By End-user

        9.5.3. By Country

10. Europe mHealth Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Connected Medical Devices

            10.2.1.1. Heart Rate Monitors

            10.2.1.2. Activity Monitors

            10.2.1.3. Electrocardiograph

            10.2.1.4. Fetal Monitoring

            10.2.1.5. Neuromonitoring

            10.2.1.6. Others

        10.2.2. mHealth Applications

            10.2.2.1. Fitness & Wellness

            10.2.2.2. Diabetes

            10.2.2.3. Cardiovascular Diseases

            10.2.2.4. Central Nervous System Diseases

            10.2.2.5. Respiratory Diseases

            10.2.2.6. Musculoskeletal Diseases

            10.2.2.7. Smoking Cessation

            10.2.2.8. Medication Adherence

            10.2.2.9. Others

        10.2.3. mHealth Services

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. B2B

            10.3.1.1. Patients

            10.3.1.2. Caregivers

        10.3.2. B2C

            10.3.2.1. Providers

            10.3.2.2. Payers

            10.3.2.3. Employers

            10.3.2.4. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific mHealth Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Connected Medical Devices

            11.2.1.1. Heart Rate Monitors

            11.2.1.2. Activity Monitors

            11.2.1.3. Electrocardiograph

            11.2.1.4. Fetal Monitoring

            11.2.1.5. Neuromonitoring

            11.2.1.6. Others

        11.2.2. mHealth Applications

            11.2.2.1. Fitness & Wellness

            11.2.2.2. Diabetes

            11.2.2.3. Cardiovascular Diseases

            11.2.2.4. Central Nervous System Diseases

            11.2.2.5. Respiratory Diseases

            11.2.2.6. Musculoskeletal Diseases

            11.2.2.7. Smoking Cessation

            11.2.2.8. Medication Adherence

            11.2.2.9. Others

        11.2.3. mHealth Services

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. B2B

            11.3.1.1. Patients

            11.3.1.2. Caregivers

        11.3.2. B2C

            11.3.2.1. Providers

            11.3.2.2. Payers

            11.3.2.3. Employers

            11.3.2.4. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Product

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America mHealth Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Connected Medical Devices

            12.2.1.1. Heart Rate Monitors

            12.2.1.2. Activity Monitors

            12.2.1.3. Electrocardiograph

            12.2.1.4. Fetal Monitoring

            12.2.1.5. Neuromonitoring

            12.2.1.6. Others

        12.2.2. mHealth Applications

            12.2.2.1. Fitness & Wellness

            12.2.2.2. Diabetes

            12.2.2.3. Cardiovascular Diseases

            12.2.2.4. Central Nervous System Diseases

            12.2.2.5. Respiratory Diseases

            12.2.2.6. Musculoskeletal Diseases

            12.2.2.7. Smoking Cessation

            12.2.2.8. Medication Adherence

            12.2.2.9. Others

        12.2.3. mHealth Services

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. B2B

            12.3.1.1. Patients

            12.3.1.2. Caregivers

        12.3.2. B2C

            12.3.2.1. Providers

            12.3.2.2. Payers

            12.3.2.3. Employers

            12.3.2.4. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Product

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa mHealth Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Connected Medical Devices

            13.2.1.1. Heart Rate Monitors

            13.2.1.2. Activity Monitors

            13.2.1.3. Electrocardiograph

            13.2.1.4. Fetal Monitoring

            13.2.1.5. Neuromonitoring

            13.2.1.6. Others

        13.2.2. mHealth Applications

            13.2.2.1. Fitness & Wellness

            13.2.2.2. Diabetes

            13.2.2.3. Cardiovascular Diseases

            13.2.2.4. Central Nervous System Diseases

            13.2.2.5. Respiratory Diseases

            13.2.2.6. Musculoskeletal Diseases

            13.2.2.7. Smoking Cessation

            13.2.2.8. Medication Adherence

            13.2.2.9. Others

        13.2.3. mHealth Services

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. B2B

            13.3.1.1. Patients

            13.3.1.2. Caregivers

        13.3.2. B2C

            13.3.2.1. Providers

            13.3.2.2. Payers

            13.3.2.3. Employers

            13.3.2.4. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Product

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of Companies)

    14.2. Market Share Analysis, by Company (2022)

    14.3. Company Profiles

        14.3.1. Dexcom, Inc.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. Financial Overview

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Apple, Inc.

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. Financial Overview

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. FitBit, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. Financial Overview

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Withings

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. Financial Overview

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. Proteus Digital Health, Inc.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. Financial Overview

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Omada Health, Inc.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. Financial Overview

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Welldoc, Inc.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. Financial Overview

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. Teladoc Health, Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. Financial Overview

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. Noom, Inc.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Product Portfolio

            14.3.9.3. Financial Overview

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. Propeller Health.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Product Portfolio

            14.3.10.3. Financial Overview

            14.3.10.4. SWOT Analysis

            14.3.10.5. Strategic Overview

        14.3.11. Canary Health

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Product Portfolio

            14.3.11.3. Financial Overview

            14.3.11.4. SWOT Analysis

            14.3.11.5. Strategic Overview

        14.3.12. BiogeniQ Inc.

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Product Portfolio

            14.3.12.3. Financial Overview

            14.3.12.4. SWOT Analysis

            14.3.12.5. Strategic Overview

        14.3.13. Glooko, Inc.

            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.13.2. Product Portfolio

            14.3.13.3. Financial Overview

            14.3.13.4. SWOT Analysis

            14.3.13.5. Strategic Overview

        14.3.14. Firstbeat Technologies

            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.14.2. Product Portfolio

            14.3.14.3. Financial Overview

            14.3.14.4. SWOT Analysis

            14.3.14.5. Strategic Overview

        14.3.15. BioTelemetry, Inc.

            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.15.2. Product Portfolio

            14.3.15.3. Financial Overview

            14.3.15.4. SWOT Analysis

            14.3.15.5. Strategic Overview

List of Tables

Table 01: Global mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global mHealth Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America mHealth Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 06: North America mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Europe mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Europe mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

Table 10: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 12: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Latin America mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Latin America mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

Table 16: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031

List of Figures

Figure 01: Global mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global mHealth Market Value Share, by Product, 2022

Figure 03: Global mHealth Market Value Share, by End-user, 2022

Figure 04: Global mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 05: Global mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 06: Global mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 07: Global mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 08: Global mHealth Market Value Share Analysis, by Region, 2022 and 2031

Figure 09: Global mHealth Market Attractiveness Analysis, by Region, 2023–2031

Figure 10: North America mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 11: North America mHealth Market Value Share Analysis, by Country, 2022 and 2031

Figure 12: North America mHealth Market Attractiveness Analysis, by Country, 2023–2031

Figure 13: North America mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 14: North America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 15: North America mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 16: North America mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 17: Europe mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 18: Europe mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 19: Europe mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 20: Europe mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 21: Europe America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 22: Europe mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 23: Europe mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 24: Asia Pacific mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 25: Asia Pacific mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 26: Asia Pacific mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 27: Asia Pacific mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 28: Asia Pacific America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 29: Asia Pacific mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 30: Asia Pacific mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 31: Latin America mHealth Market Value (US$ Mn) Forecast, 2017–2031

Figure 32: Latin America mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 33: Latin America mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 34: Latin America mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 35: Latin America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 36: Middle East & Africa mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 37: Middle East & Africa mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 38: Middle East & Africa America mHealth Market Value Share Analysis, by Product, 2022 and 2031

Figure 39: Middle East & Africa America mHealth Market Attractiveness Analysis, by Product, 2023–2031

Figure 40: Middle East & Africa mHealth Market Value Share Analysis, by End-user, 2022 and 2031

Figure 41: Middle East & Africa mHealth Market Attractiveness Analysis, by End-user 2023–2031

Figure 42: Global mHealth Market Share Analysis, by Company (2022)

Copyright © Transparency Market Research, Inc. All Rights reserved